Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Lexeo Therapeutics, Inc. (LXEO) had Free Cash Flow per Share of $-1.13 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-26.10M |
|
-- |
|
-- |
|
$30.69M |
|
$-30.69M |
|
$4.58M |
|
$-26.10M |
|
$-29.49M |
|
$-26.10M |
|
$-26.10M |
|
$-26.10M |
|
$-29.49M |
|
$-30.69M |
|
$-30.58M |
|
43.57M |
|
43.57M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$140.06M |
|
$1.11M |
|
$36.01M |
|
$176.07M |
|
$31.59M |
|
$0.58M |
|
$6.26M |
|
$37.85M |
|
$138.22M |
|
$138.22M |
|
$138.22M |
|
54.00M |
|
| Cash Flow Statement Financials | |
$-48.94M |
|
$-23.57M |
|
$72.97M |
|
$38.27M |
|
$38.73M |
|
$0.46M |
|
$6.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.43 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.89% |
|
-18.89% |
|
-14.83% |
|
-18.81% |
|
$2.56 |
|
|
Free Cash Flow per Share |
$-1.13 |
$-1.12 |
|